Viva Biotech Holdings (OTCMKTS:VBIZF) Sees Significant Increase in Short Interest

Viva Biotech Holdings (OTCMKTS:VBIZFGet Free Report) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 3,320,100 shares, an increase of 29.5% from the January 31st total of 2,563,100 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 33,201.0 days.

Viva Biotech Trading Up 33.4 %

Shares of OTCMKTS VBIZF opened at $0.11 on Monday. The firm’s 50-day simple moving average is $0.10 and its 200 day simple moving average is $0.13. Viva Biotech has a 12-month low of $0.08 and a 12-month high of $0.23.

About Viva Biotech

(Get Free Report)

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure analysis of protein, and SPR technology; and PROTAC/molecular glue services.

Featured Articles

Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.